Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

The G-Protein-Coupled Estrogen Receptor (GPER/GPR30) in Ovarian Granulosa Cell Tumors.

Heublein S, Mayr D, Friese K, Jarrin-Franco MC, Lenhard M, Mayerhofer A, Jeschke U.

Int J Mol Sci. 2014 Aug 27;15(9):15161-15172.

PMID:
25167139
[PubMed - as supplied by publisher]
2.

Strong correlation between N-cadherin and CD133 in breast cancer: role of both markers in metastatic events.

Bock C, Kuhn C, Ditsch N, Krebold R, Heublein S, Mayr D, Doisneau-Sixou S, Jeschke U.

J Cancer Res Clin Oncol. 2014 Jun 25. [Epub ahead of print]

PMID:
24962344
[PubMed - as supplied by publisher]
3.

Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.

Kirn V, Shi R, Heublein S, Knabl J, Guenthner-Biller M, Andergassen U, Fridrich C, Malter W, Harder J, Friese K, Mayr D, Jeschke U.

J Cancer Res Clin Oncol. 2014 Jun 8. [Epub ahead of print]

PMID:
24908329
[PubMed - as supplied by publisher]
4.

ESR1 promoter methylation in squamous cell cervical cancer.

Kirn V, Zaharieva I, Heublein S, Thangarajah F, Friese K, Mayr D, Jeschke U.

Anticancer Res. 2014 Feb;34(2):723-7.

PMID:
24511005
[PubMed - indexed for MEDLINE]
5.

Detection and characterisation of disseminated tumour cells in bone marrow of breast cancer patients by immunostaining of Her-2 and MUC-1 in combination with Thomsen-Friedenreich (CD176).

Andergassen U, Kölbl AC, Zebisch M, Heublein S, Hutter S, Ilmer M, Schindlbeck C, Friese K, Jeschke U.

Histol Histopathol. 2014 Jul;29(7):913-23. Epub 2014 Jan 8.

PMID:
24399516
[PubMed - in process]
6.

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.

Lenhard M, Heublein S, Kunert-Keil C, Vrekoussis T, Lomba I, Ditsch N, Mayr D, Friese K, Jeschke U.

BMC Cancer. 2013 Dec 30;13:616. doi: 10.1186/1471-2407-13-616.

PMID:
24377825
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Significance of the tumor protease cathepsin D for the biology of breast cancer.

Dian D, Heublein S, Wiest I, Barthell L, Friese K, Jeschke U.

Histol Histopathol. 2014 Apr;29(4):433-8. Epub 2013 Nov 22.

PMID:
24265119
[PubMed - in process]
8.

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.

Heublein S, Grasse K, Hessel H, Burges A, Lenhard M, Engel J, Kirchner T, Jeschke U, Mayr D.

BMC Cancer. 2013 Oct 18;13:483. doi: 10.1186/1471-2407-13-483.

PMID:
24139521
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.

Heublein S, Mayr D, Vrekoussis T, Friese K, Hofmann SS, Jeschke U, Lenhard M.

PLoS One. 2013 Aug 9;8(8):e71791. doi: 10.1371/journal.pone.0071791. eCollection 2013.

PMID:
23951246
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Expression and function of galectins in the endometrium and at the human feto-maternal interface.

Jeschke U, Hutter S, Heublein S, Vrekoussis T, Andergassen U, Unverdorben L, Papadakis G, Makrigiannakis A.

Placenta. 2013 Oct;34(10):863-72. doi: 10.1016/j.placenta.2013.07.005. Epub 2013 Jul 30. Review.

PMID:
23911101
[PubMed - indexed for MEDLINE]
11.

Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology.

Weissenbacher T, Hirte E, Kuhn C, Janni W, Mayr D, Karsten U, Rack B, Friese K, Jeschke U, Heublein S, Dian D, Ditsch N.

BMC Cancer. 2013 Jul 26;13:361. doi: 10.1186/1471-2407-13-361.

PMID:
23890049
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Macrophages: are they involved in endometriosis, abortion and preeclampsia and how?

Hutter S, Heublein S, Knabl J, Andergassen U, Vrekoussis T, Makrigiannakis A, Friese K, Mayr D, Jeschke U.

J Nippon Med Sch. 2013;80(2):97-103. Review.

PMID:
23657062
[PubMed - indexed for MEDLINE]
Free Article
13.

Detection of breast cancer cells in blood samples by immunostaining of the Thomsen-Friedenreich antigen.

Andergassen U, Zebisch M, Kölbl AC, Schindlbeck C, Ilmer M, Hutter S, Heublein S, Rack B, Friese K, Jeschke U.

Future Oncol. 2013 May;9(5):747-52. doi: 10.2217/fon.13.24.

PMID:
23647302
[PubMed - indexed for MEDLINE]
14.

Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturation.

Heublein S, Vrekoussis T, Kuhn C, Friese K, Makrigiannakis A, Mayr D, Lenhard M, Jeschke U.

J Reprod Immunol. 2013 Mar;97(1):95-103. doi: 10.1016/j.jri.2012.10.013.

PMID:
23432876
[PubMed - indexed for MEDLINE]
15.

Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in Germany.

Heublein S, Wehner F, Höchsmann B, Hochhaus A, Hartmann M, La Rosée P.

Ann Hematol. 2013 Jun;92(6):825-30. doi: 10.1007/s00277-013-1688-2. Epub 2013 Feb 13.

PMID:
23404582
[PubMed - indexed for MEDLINE]
16.

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR).

Heublein S, Vrekoussis T, Mayr D, Friese K, Lenhard M, Jeschke U, Dian D.

J Ovarian Res. 2013 Jan 22;6(1):6. doi: 10.1186/1757-2215-6-6.

PMID:
23339713
[PubMed]
Free PMC Article
17.

Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8.

Dian D, Lenhard M, Mayr D, Heublein S, Karsten U, Goletz S, Kuhn C, Wiest I, Friese K, Weissenbacher T, Jeschke U.

Histol Histopathol. 2013 Feb;28(2):239-44.

PMID:
23275306
[PubMed - indexed for MEDLINE]
18.

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients.

Engelstaedter V, Heublein S, Schumacher AL, Lenhard M, Engelstaedter H, Andergassen U, Guenthner-Biller M, Kuhn C, Rack B, Kupka M, Mayr D, Jeschke U.

BMC Cancer. 2012 Dec 15;12:600. doi: 10.1186/1471-2407-12-600.

PMID:
23241107
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Quantification of breast cancer cells in peripheral blood samples by real-time rt-PCR.

Zebisch M, Kölbl AC, Schindlbeck C, Neugebauer J, Heublein S, Ilmer M, Rack B, Friese K, Jeschke U, Andergassen U.

Anticancer Res. 2012 Dec;32(12):5387-91.

PMID:
23225441
[PubMed - indexed for MEDLINE]
20.

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

Lenhard M, Tereza L, Heublein S, Ditsch N, Himsl I, Mayr D, Friese K, Jeschke U.

BMC Cancer. 2012 Nov 24;12:553. doi: 10.1186/1471-2407-12-553.

PMID:
23176303
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk